Helen H Chen (Helen Chen)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

JMIR cardio

Future oncology (London, England)

PharmacoEconomics

JMIR mHealth and uHealth

University of Waterloo

University of Waterloo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Waterloo Oct 01 2009

Canada

Professor of Practice :: School of Public Health and Health Systems

Education History

University of Waterloo May 01 1993 - Feb 28 1998

Canada

PHD :: Civil Engineering

Tsinghua University Sep 01 1987 - Nov 30 1989

China

MSC :: Engineering Mechanics

Publications

Guangxia Meng, Carrie McAiney, Ian McKillop, Christopher M Perlman, Shu-Feng Tsao, Helen H Chen
Factors That Influence Patient Satisfaction With the Service Quality of Home-Based Teleconsultation During the COVID-19 Pandemic: Cross-Sectional Survey Study. JMIR cardio 8 (2024)
Guangxia Meng, Carrie McAiney, Ian McKillop, Christopher M Perlman, Shu-Feng Tsao, Helen H Chen
Factors That Influence Patient Satisfaction With the Service Quality of Home-Based Teleconsultation During the COVID-19 Pandemic: Cross-Sectional Survey Study. JMIR cardio 8 (2024)
Guangxia Meng, Carrie McAiney, Ian McKillop, Christopher M Perlman, Shu-Feng Tsao, Helen H Chen
Factors That Influence Patient Satisfaction With the Service Quality of Home-Based Teleconsultation During the COVID-19 Pandemic: Cross-Sectional Survey Study. JMIR cardio 8 (2024)
Yong-Jin Kim, Mark Oremus, Helen H Chen, Thomas McFarlane, Danielle Fearon, Susan Horton
Factors affecting treatment selection and overall survival for first-line EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer. Journal of comparative effectiveness research 10 (3) (2021)
Yong-Jin Kim, Mark Oremus, Helen H Chen, Thomas McFarlane, Danielle Fearon, Susan Horton
Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada. PharmacoEconomics 39 (5) (2021)
Yang Yang, Helen H Chen, Hammad Qazi, Plinio Pelegrini Morita
Intervention and Evaluation of Mobile Health Technologies in Management of Patients Undergoing Chronic Dialysis: Scoping Review. JMIR mHealth and uHealth 8 (4) (2020)
Yong-Jin Kim, Mark Oremus, Helen H Chen, Thomas McFarlane, Devanshi Shah, Susan Horton
Real-world effectiveness of nivolumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis. Future oncology (London, England) 16 (27) (2020)

Helen H Chen.css-eqlu8i{font-size:small;padding-left:4px;} (Helen Chen)

Publication Activity (10 Years)

Top Topics

Top Venues

Helen H Chen (Helen Chen)